Global Recombinant FSH Injections Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.
Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.
The global Recombinant FSH Injections market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Recombinant FSH Injections Industry Forecast” looks at past sales and reviews total world Recombinant FSH Injections sales in 2023, providing a comprehensive analysis by region and market sector of projected Recombinant FSH Injections sales for 2024 through 2030. With Recombinant FSH Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant FSH Injections industry.
This Insight Report provides a comprehensive analysis of the global Recombinant FSH Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant FSH Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant FSH Injections market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant FSH Injections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant FSH Injections.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant FSH Injections market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
What is the 10-year outlook for the global Recombinant FSH Injections market?
What factors are driving Recombinant FSH Injections market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant FSH Injections market opportunities vary by end market size?
How does Recombinant FSH Injections break out type, application?
Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.
Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.
The global Recombinant FSH Injections market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Recombinant FSH Injections Industry Forecast” looks at past sales and reviews total world Recombinant FSH Injections sales in 2023, providing a comprehensive analysis by region and market sector of projected Recombinant FSH Injections sales for 2024 through 2030. With Recombinant FSH Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant FSH Injections industry.
This Insight Report provides a comprehensive analysis of the global Recombinant FSH Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant FSH Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant FSH Injections market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant FSH Injections and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant FSH Injections.
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant FSH Injections market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- Powder
- Liquid
- IVF and Embryo Transfer
- Infertility Treatment
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gonal-F (Merck)
- Follistim (Organon)
- Bravelle (Ferring)
- Menopur (Ferring)
- Fostimon (IBSA)
- Puregon (Organon)
- BEMFOLA (Gedeon Richter)
- Follitrope (LG Chem)
- GenSci
What is the 10-year outlook for the global Recombinant FSH Injections market?
What factors are driving Recombinant FSH Injections market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant FSH Injections market opportunities vary by end market size?
How does Recombinant FSH Injections break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant FSH Injections Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Recombinant FSH Injections by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Recombinant FSH Injections by Country/Region, 2019, 2023 & 2030
2.2 Recombinant FSH Injections Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.3 Recombinant FSH Injections Sales by Type
2.3.1 Global Recombinant FSH Injections Sales Market Share by Type (2019-2024)
2.3.2 Global Recombinant FSH Injections Revenue and Market Share by Type (2019-2024)
2.3.3 Global Recombinant FSH Injections Sale Price by Type (2019-2024)
2.4 Recombinant FSH Injections Segment by Application
2.4.1 IVF and Embryo Transfer
2.4.2 Infertility Treatment
2.5 Recombinant FSH Injections Sales by Application
2.5.1 Global Recombinant FSH Injections Sale Market Share by Application (2019-2024)
2.5.2 Global Recombinant FSH Injections Revenue and Market Share by Application (2019-2024)
2.5.3 Global Recombinant FSH Injections Sale Price by Application (2019-2024)
3 GLOBAL RECOMBINANT FSH INJECTIONS BY COMPANY
3.1 Global Recombinant FSH Injections Breakdown Data by Company
3.1.1 Global Recombinant FSH Injections Annual Sales by Company (2019-2024)
3.1.2 Global Recombinant FSH Injections Sales Market Share by Company (2019-2024)
3.2 Global Recombinant FSH Injections Annual Revenue by Company (2019-2024)
3.2.1 Global Recombinant FSH Injections Revenue by Company (2019-2024)
3.2.2 Global Recombinant FSH Injections Revenue Market Share by Company (2019-2024)
3.3 Global Recombinant FSH Injections Sale Price by Company
3.4 Key Manufacturers Recombinant FSH Injections Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant FSH Injections Product Location Distribution
3.4.2 Players Recombinant FSH Injections Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT FSH INJECTIONS BY GEOGRAPHIC REGION
4.1 World Historic Recombinant FSH Injections Market Size by Geographic Region (2019-2024)
4.1.1 Global Recombinant FSH Injections Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Recombinant FSH Injections Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Recombinant FSH Injections Market Size by Country/Region (2019-2024)
4.2.1 Global Recombinant FSH Injections Annual Sales by Country/Region (2019-2024)
4.2.2 Global Recombinant FSH Injections Annual Revenue by Country/Region (2019-2024)
4.3 Americas Recombinant FSH Injections Sales Growth
4.4 APAC Recombinant FSH Injections Sales Growth
4.5 Europe Recombinant FSH Injections Sales Growth
4.6 Middle East & Africa Recombinant FSH Injections Sales Growth
5 AMERICAS
5.1 Americas Recombinant FSH Injections Sales by Country
5.1.1 Americas Recombinant FSH Injections Sales by Country (2019-2024)
5.1.2 Americas Recombinant FSH Injections Revenue by Country (2019-2024)
5.2 Americas Recombinant FSH Injections Sales by Type
5.3 Americas Recombinant FSH Injections Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant FSH Injections Sales by Region
6.1.1 APAC Recombinant FSH Injections Sales by Region (2019-2024)
6.1.2 APAC Recombinant FSH Injections Revenue by Region (2019-2024)
6.2 APAC Recombinant FSH Injections Sales by Type
6.3 APAC Recombinant FSH Injections Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant FSH Injections by Country
7.1.1 Europe Recombinant FSH Injections Sales by Country (2019-2024)
7.1.2 Europe Recombinant FSH Injections Revenue by Country (2019-2024)
7.2 Europe Recombinant FSH Injections Sales by Type
7.3 Europe Recombinant FSH Injections Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant FSH Injections by Country
8.1.1 Middle East & Africa Recombinant FSH Injections Sales by Country (2019-2024)
8.1.2 Middle East & Africa Recombinant FSH Injections Revenue by Country (2019-2024)
8.2 Middle East & Africa Recombinant FSH Injections Sales by Type
8.3 Middle East & Africa Recombinant FSH Injections Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant FSH Injections
10.3 Manufacturing Process Analysis of Recombinant FSH Injections
10.4 Industry Chain Structure of Recombinant FSH Injections
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant FSH Injections Distributors
11.3 Recombinant FSH Injections Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT FSH INJECTIONS BY GEOGRAPHIC REGION
12.1 Global Recombinant FSH Injections Market Size Forecast by Region
12.1.1 Global Recombinant FSH Injections Forecast by Region (2025-2030)
12.1.2 Global Recombinant FSH Injections Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant FSH Injections Forecast by Type
12.7 Global Recombinant FSH Injections Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Gonal-F (Merck)
13.1.1 Gonal-F (Merck) Company Information
13.1.2 Gonal-F (Merck) Recombinant FSH Injections Product Portfolios and Specifications
13.1.3 Gonal-F (Merck) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Gonal-F (Merck) Main Business Overview
13.1.5 Gonal-F (Merck) Latest Developments
13.2 Follistim (Organon)
13.2.1 Follistim (Organon) Company Information
13.2.2 Follistim (Organon) Recombinant FSH Injections Product Portfolios and Specifications
13.2.3 Follistim (Organon) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Follistim (Organon) Main Business Overview
13.2.5 Follistim (Organon) Latest Developments
13.3 Bravelle (Ferring)
13.3.1 Bravelle (Ferring) Company Information
13.3.2 Bravelle (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
13.3.3 Bravelle (Ferring) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bravelle (Ferring) Main Business Overview
13.3.5 Bravelle (Ferring) Latest Developments
13.4 Menopur (Ferring)
13.4.1 Menopur (Ferring) Company Information
13.4.2 Menopur (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
13.4.3 Menopur (Ferring) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Menopur (Ferring) Main Business Overview
13.4.5 Menopur (Ferring) Latest Developments
13.5 Fostimon (IBSA)
13.5.1 Fostimon (IBSA) Company Information
13.5.2 Fostimon (IBSA) Recombinant FSH Injections Product Portfolios and Specifications
13.5.3 Fostimon (IBSA) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Fostimon (IBSA) Main Business Overview
13.5.5 Fostimon (IBSA) Latest Developments
13.6 Puregon (Organon)
13.6.1 Puregon (Organon) Company Information
13.6.2 Puregon (Organon) Recombinant FSH Injections Product Portfolios and Specifications
13.6.3 Puregon (Organon) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Puregon (Organon) Main Business Overview
13.6.5 Puregon (Organon) Latest Developments
13.7 BEMFOLA (Gedeon Richter)
13.7.1 BEMFOLA (Gedeon Richter) Company Information
13.7.2 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product Portfolios and Specifications
13.7.3 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 BEMFOLA (Gedeon Richter) Main Business Overview
13.7.5 BEMFOLA (Gedeon Richter) Latest Developments
13.8 Follitrope (LG Chem)
13.8.1 Follitrope (LG Chem) Company Information
13.8.2 Follitrope (LG Chem) Recombinant FSH Injections Product Portfolios and Specifications
13.8.3 Follitrope (LG Chem) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Follitrope (LG Chem) Main Business Overview
13.8.5 Follitrope (LG Chem) Latest Developments
13.9 GenSci
13.9.1 GenSci Company Information
13.9.2 GenSci Recombinant FSH Injections Product Portfolios and Specifications
13.9.3 GenSci Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 GenSci Main Business Overview
13.9.5 GenSci Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant FSH Injections Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Recombinant FSH Injections by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Recombinant FSH Injections by Country/Region, 2019, 2023 & 2030
2.2 Recombinant FSH Injections Segment by Type
2.2.1 Powder
2.2.2 Liquid
2.3 Recombinant FSH Injections Sales by Type
2.3.1 Global Recombinant FSH Injections Sales Market Share by Type (2019-2024)
2.3.2 Global Recombinant FSH Injections Revenue and Market Share by Type (2019-2024)
2.3.3 Global Recombinant FSH Injections Sale Price by Type (2019-2024)
2.4 Recombinant FSH Injections Segment by Application
2.4.1 IVF and Embryo Transfer
2.4.2 Infertility Treatment
2.5 Recombinant FSH Injections Sales by Application
2.5.1 Global Recombinant FSH Injections Sale Market Share by Application (2019-2024)
2.5.2 Global Recombinant FSH Injections Revenue and Market Share by Application (2019-2024)
2.5.3 Global Recombinant FSH Injections Sale Price by Application (2019-2024)
3 GLOBAL RECOMBINANT FSH INJECTIONS BY COMPANY
3.1 Global Recombinant FSH Injections Breakdown Data by Company
3.1.1 Global Recombinant FSH Injections Annual Sales by Company (2019-2024)
3.1.2 Global Recombinant FSH Injections Sales Market Share by Company (2019-2024)
3.2 Global Recombinant FSH Injections Annual Revenue by Company (2019-2024)
3.2.1 Global Recombinant FSH Injections Revenue by Company (2019-2024)
3.2.2 Global Recombinant FSH Injections Revenue Market Share by Company (2019-2024)
3.3 Global Recombinant FSH Injections Sale Price by Company
3.4 Key Manufacturers Recombinant FSH Injections Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant FSH Injections Product Location Distribution
3.4.2 Players Recombinant FSH Injections Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT FSH INJECTIONS BY GEOGRAPHIC REGION
4.1 World Historic Recombinant FSH Injections Market Size by Geographic Region (2019-2024)
4.1.1 Global Recombinant FSH Injections Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Recombinant FSH Injections Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Recombinant FSH Injections Market Size by Country/Region (2019-2024)
4.2.1 Global Recombinant FSH Injections Annual Sales by Country/Region (2019-2024)
4.2.2 Global Recombinant FSH Injections Annual Revenue by Country/Region (2019-2024)
4.3 Americas Recombinant FSH Injections Sales Growth
4.4 APAC Recombinant FSH Injections Sales Growth
4.5 Europe Recombinant FSH Injections Sales Growth
4.6 Middle East & Africa Recombinant FSH Injections Sales Growth
5 AMERICAS
5.1 Americas Recombinant FSH Injections Sales by Country
5.1.1 Americas Recombinant FSH Injections Sales by Country (2019-2024)
5.1.2 Americas Recombinant FSH Injections Revenue by Country (2019-2024)
5.2 Americas Recombinant FSH Injections Sales by Type
5.3 Americas Recombinant FSH Injections Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant FSH Injections Sales by Region
6.1.1 APAC Recombinant FSH Injections Sales by Region (2019-2024)
6.1.2 APAC Recombinant FSH Injections Revenue by Region (2019-2024)
6.2 APAC Recombinant FSH Injections Sales by Type
6.3 APAC Recombinant FSH Injections Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant FSH Injections by Country
7.1.1 Europe Recombinant FSH Injections Sales by Country (2019-2024)
7.1.2 Europe Recombinant FSH Injections Revenue by Country (2019-2024)
7.2 Europe Recombinant FSH Injections Sales by Type
7.3 Europe Recombinant FSH Injections Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant FSH Injections by Country
8.1.1 Middle East & Africa Recombinant FSH Injections Sales by Country (2019-2024)
8.1.2 Middle East & Africa Recombinant FSH Injections Revenue by Country (2019-2024)
8.2 Middle East & Africa Recombinant FSH Injections Sales by Type
8.3 Middle East & Africa Recombinant FSH Injections Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant FSH Injections
10.3 Manufacturing Process Analysis of Recombinant FSH Injections
10.4 Industry Chain Structure of Recombinant FSH Injections
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant FSH Injections Distributors
11.3 Recombinant FSH Injections Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT FSH INJECTIONS BY GEOGRAPHIC REGION
12.1 Global Recombinant FSH Injections Market Size Forecast by Region
12.1.1 Global Recombinant FSH Injections Forecast by Region (2025-2030)
12.1.2 Global Recombinant FSH Injections Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant FSH Injections Forecast by Type
12.7 Global Recombinant FSH Injections Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Gonal-F (Merck)
13.1.1 Gonal-F (Merck) Company Information
13.1.2 Gonal-F (Merck) Recombinant FSH Injections Product Portfolios and Specifications
13.1.3 Gonal-F (Merck) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Gonal-F (Merck) Main Business Overview
13.1.5 Gonal-F (Merck) Latest Developments
13.2 Follistim (Organon)
13.2.1 Follistim (Organon) Company Information
13.2.2 Follistim (Organon) Recombinant FSH Injections Product Portfolios and Specifications
13.2.3 Follistim (Organon) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Follistim (Organon) Main Business Overview
13.2.5 Follistim (Organon) Latest Developments
13.3 Bravelle (Ferring)
13.3.1 Bravelle (Ferring) Company Information
13.3.2 Bravelle (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
13.3.3 Bravelle (Ferring) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bravelle (Ferring) Main Business Overview
13.3.5 Bravelle (Ferring) Latest Developments
13.4 Menopur (Ferring)
13.4.1 Menopur (Ferring) Company Information
13.4.2 Menopur (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
13.4.3 Menopur (Ferring) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Menopur (Ferring) Main Business Overview
13.4.5 Menopur (Ferring) Latest Developments
13.5 Fostimon (IBSA)
13.5.1 Fostimon (IBSA) Company Information
13.5.2 Fostimon (IBSA) Recombinant FSH Injections Product Portfolios and Specifications
13.5.3 Fostimon (IBSA) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Fostimon (IBSA) Main Business Overview
13.5.5 Fostimon (IBSA) Latest Developments
13.6 Puregon (Organon)
13.6.1 Puregon (Organon) Company Information
13.6.2 Puregon (Organon) Recombinant FSH Injections Product Portfolios and Specifications
13.6.3 Puregon (Organon) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Puregon (Organon) Main Business Overview
13.6.5 Puregon (Organon) Latest Developments
13.7 BEMFOLA (Gedeon Richter)
13.7.1 BEMFOLA (Gedeon Richter) Company Information
13.7.2 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product Portfolios and Specifications
13.7.3 BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 BEMFOLA (Gedeon Richter) Main Business Overview
13.7.5 BEMFOLA (Gedeon Richter) Latest Developments
13.8 Follitrope (LG Chem)
13.8.1 Follitrope (LG Chem) Company Information
13.8.2 Follitrope (LG Chem) Recombinant FSH Injections Product Portfolios and Specifications
13.8.3 Follitrope (LG Chem) Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Follitrope (LG Chem) Main Business Overview
13.8.5 Follitrope (LG Chem) Latest Developments
13.9 GenSci
13.9.1 GenSci Company Information
13.9.2 GenSci Recombinant FSH Injections Product Portfolios and Specifications
13.9.3 GenSci Recombinant FSH Injections Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 GenSci Main Business Overview
13.9.5 GenSci Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant FSH Injections Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Recombinant FSH Injections Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Recombinant FSH Injections Sales by Type (2019-2024) & (K Units)
Table 6. Global Recombinant FSH Injections Sales Market Share by Type (2019-2024)
Table 7. Global Recombinant FSH Injections Revenue by Type (2019-2024) & ($ million)
Table 8. Global Recombinant FSH Injections Revenue Market Share by Type (2019-2024)
Table 9. Global Recombinant FSH Injections Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Recombinant FSH Injections Sales by Application (2019-2024) & (K Units)
Table 11. Global Recombinant FSH Injections Sales Market Share by Application (2019-2024)
Table 12. Global Recombinant FSH Injections Revenue by Application (2019-2024)
Table 13. Global Recombinant FSH Injections Revenue Market Share by Application (2019-2024)
Table 14. Global Recombinant FSH Injections Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Recombinant FSH Injections Sales by Company (2019-2024) & (K Units)
Table 16. Global Recombinant FSH Injections Sales Market Share by Company (2019-2024)
Table 17. Global Recombinant FSH Injections Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Recombinant FSH Injections Revenue Market Share by Company (2019-2024)
Table 19. Global Recombinant FSH Injections Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Recombinant FSH Injections Producing Area Distribution and Sales Area
Table 21. Players Recombinant FSH Injections Products Offered
Table 22. Recombinant FSH Injections Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Recombinant FSH Injections Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Recombinant FSH Injections Sales Market Share Geographic Region (2019-2024)
Table 27. Global Recombinant FSH Injections Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Recombinant FSH Injections Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Recombinant FSH Injections Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Recombinant FSH Injections Sales Market Share by Country/Region (2019-2024)
Table 31. Global Recombinant FSH Injections Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Recombinant FSH Injections Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Recombinant FSH Injections Sales by Country (2019-2024) & (K Units)
Table 34. Americas Recombinant FSH Injections Sales Market Share by Country (2019-2024)
Table 35. Americas Recombinant FSH Injections Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Recombinant FSH Injections Revenue Market Share by Country (2019-2024)
Table 37. Americas Recombinant FSH Injections Sales by Type (2019-2024) & (K Units)
Table 38. Americas Recombinant FSH Injections Sales by Application (2019-2024) & (K Units)
Table 39. APAC Recombinant FSH Injections Sales by Region (2019-2024) & (K Units)
Table 40. APAC Recombinant FSH Injections Sales Market Share by Region (2019-2024)
Table 41. APAC Recombinant FSH Injections Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Recombinant FSH Injections Revenue Market Share by Region (2019-2024)
Table 43. APAC Recombinant FSH Injections Sales by Type (2019-2024) & (K Units)
Table 44. APAC Recombinant FSH Injections Sales by Application (2019-2024) & (K Units)
Table 45. Europe Recombinant FSH Injections Sales by Country (2019-2024) & (K Units)
Table 46. Europe Recombinant FSH Injections Sales Market Share by Country (2019-2024)
Table 47. Europe Recombinant FSH Injections Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Recombinant FSH Injections Revenue Market Share by Country (2019-2024)
Table 49. Europe Recombinant FSH Injections Sales by Type (2019-2024) & (K Units)
Table 50. Europe Recombinant FSH Injections Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Recombinant FSH Injections Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Recombinant FSH Injections Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Recombinant FSH Injections Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Recombinant FSH Injections Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Recombinant FSH Injections Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Recombinant FSH Injections Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Recombinant FSH Injections
Table 58. Key Market Challenges & Risks of Recombinant FSH Injections
Table 59. Key Industry Trends of Recombinant FSH Injections
Table 60. Recombinant FSH Injections Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Recombinant FSH Injections Distributors List
Table 63. Recombinant FSH Injections Customer List
Table 64. Global Recombinant FSH Injections Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Recombinant FSH Injections Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Recombinant FSH Injections Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Recombinant FSH Injections Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Recombinant FSH Injections Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Recombinant FSH Injections Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Recombinant FSH Injections Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Recombinant FSH Injections Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Recombinant FSH Injections Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Recombinant FSH Injections Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Recombinant FSH Injections Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Recombinant FSH Injections Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Recombinant FSH Injections Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Recombinant FSH Injections Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Gonal-F (Merck) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 79. Gonal-F (Merck) Recombinant FSH Injections Product Portfolios and Specifications
Table 80. Gonal-F (Merck) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Gonal-F (Merck) Main Business
Table 82. Gonal-F (Merck) Latest Developments
Table 83. Follistim (Organon) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 84. Follistim (Organon) Recombinant FSH Injections Product Portfolios and Specifications
Table 85. Follistim (Organon) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Follistim (Organon) Main Business
Table 87. Follistim (Organon) Latest Developments
Table 88. Bravelle (Ferring) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 89. Bravelle (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
Table 90. Bravelle (Ferring) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Bravelle (Ferring) Main Business
Table 92. Bravelle (Ferring) Latest Developments
Table 93. Menopur (Ferring) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 94. Menopur (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
Table 95. Menopur (Ferring) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Menopur (Ferring) Main Business
Table 97. Menopur (Ferring) Latest Developments
Table 98. Fostimon (IBSA) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 99. Fostimon (IBSA) Recombinant FSH Injections Product Portfolios and Specifications
Table 100. Fostimon (IBSA) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Fostimon (IBSA) Main Business
Table 102. Fostimon (IBSA) Latest Developments
Table 103. Puregon (Organon) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 104. Puregon (Organon) Recombinant FSH Injections Product Portfolios and Specifications
Table 105. Puregon (Organon) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Puregon (Organon) Main Business
Table 107. Puregon (Organon) Latest Developments
Table 108. BEMFOLA (Gedeon Richter) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 109. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product Portfolios and Specifications
Table 110. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. BEMFOLA (Gedeon Richter) Main Business
Table 112. BEMFOLA (Gedeon Richter) Latest Developments
Table 113. Follitrope (LG Chem) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 114. Follitrope (LG Chem) Recombinant FSH Injections Product Portfolios and Specifications
Table 115. Follitrope (LG Chem) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Follitrope (LG Chem) Main Business
Table 117. Follitrope (LG Chem) Latest Developments
Table 118. GenSci Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 119. GenSci Recombinant FSH Injections Product Portfolios and Specifications
Table 120. GenSci Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. GenSci Main Business
Table 122. GenSci Latest Developments
Table 1. Recombinant FSH Injections Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Recombinant FSH Injections Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Powder
Table 4. Major Players of Liquid
Table 5. Global Recombinant FSH Injections Sales by Type (2019-2024) & (K Units)
Table 6. Global Recombinant FSH Injections Sales Market Share by Type (2019-2024)
Table 7. Global Recombinant FSH Injections Revenue by Type (2019-2024) & ($ million)
Table 8. Global Recombinant FSH Injections Revenue Market Share by Type (2019-2024)
Table 9. Global Recombinant FSH Injections Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Recombinant FSH Injections Sales by Application (2019-2024) & (K Units)
Table 11. Global Recombinant FSH Injections Sales Market Share by Application (2019-2024)
Table 12. Global Recombinant FSH Injections Revenue by Application (2019-2024)
Table 13. Global Recombinant FSH Injections Revenue Market Share by Application (2019-2024)
Table 14. Global Recombinant FSH Injections Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Recombinant FSH Injections Sales by Company (2019-2024) & (K Units)
Table 16. Global Recombinant FSH Injections Sales Market Share by Company (2019-2024)
Table 17. Global Recombinant FSH Injections Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Recombinant FSH Injections Revenue Market Share by Company (2019-2024)
Table 19. Global Recombinant FSH Injections Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Recombinant FSH Injections Producing Area Distribution and Sales Area
Table 21. Players Recombinant FSH Injections Products Offered
Table 22. Recombinant FSH Injections Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Recombinant FSH Injections Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Recombinant FSH Injections Sales Market Share Geographic Region (2019-2024)
Table 27. Global Recombinant FSH Injections Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Recombinant FSH Injections Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Recombinant FSH Injections Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Recombinant FSH Injections Sales Market Share by Country/Region (2019-2024)
Table 31. Global Recombinant FSH Injections Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Recombinant FSH Injections Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Recombinant FSH Injections Sales by Country (2019-2024) & (K Units)
Table 34. Americas Recombinant FSH Injections Sales Market Share by Country (2019-2024)
Table 35. Americas Recombinant FSH Injections Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Recombinant FSH Injections Revenue Market Share by Country (2019-2024)
Table 37. Americas Recombinant FSH Injections Sales by Type (2019-2024) & (K Units)
Table 38. Americas Recombinant FSH Injections Sales by Application (2019-2024) & (K Units)
Table 39. APAC Recombinant FSH Injections Sales by Region (2019-2024) & (K Units)
Table 40. APAC Recombinant FSH Injections Sales Market Share by Region (2019-2024)
Table 41. APAC Recombinant FSH Injections Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Recombinant FSH Injections Revenue Market Share by Region (2019-2024)
Table 43. APAC Recombinant FSH Injections Sales by Type (2019-2024) & (K Units)
Table 44. APAC Recombinant FSH Injections Sales by Application (2019-2024) & (K Units)
Table 45. Europe Recombinant FSH Injections Sales by Country (2019-2024) & (K Units)
Table 46. Europe Recombinant FSH Injections Sales Market Share by Country (2019-2024)
Table 47. Europe Recombinant FSH Injections Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Recombinant FSH Injections Revenue Market Share by Country (2019-2024)
Table 49. Europe Recombinant FSH Injections Sales by Type (2019-2024) & (K Units)
Table 50. Europe Recombinant FSH Injections Sales by Application (2019-2024) & (K Units)
Table 51. Middle East & Africa Recombinant FSH Injections Sales by Country (2019-2024) & (K Units)
Table 52. Middle East & Africa Recombinant FSH Injections Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Recombinant FSH Injections Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Recombinant FSH Injections Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Recombinant FSH Injections Sales by Type (2019-2024) & (K Units)
Table 56. Middle East & Africa Recombinant FSH Injections Sales by Application (2019-2024) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Recombinant FSH Injections
Table 58. Key Market Challenges & Risks of Recombinant FSH Injections
Table 59. Key Industry Trends of Recombinant FSH Injections
Table 60. Recombinant FSH Injections Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Recombinant FSH Injections Distributors List
Table 63. Recombinant FSH Injections Customer List
Table 64. Global Recombinant FSH Injections Sales Forecast by Region (2025-2030) & (K Units)
Table 65. Global Recombinant FSH Injections Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Recombinant FSH Injections Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Americas Recombinant FSH Injections Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Recombinant FSH Injections Sales Forecast by Region (2025-2030) & (K Units)
Table 69. APAC Recombinant FSH Injections Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Recombinant FSH Injections Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Europe Recombinant FSH Injections Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Recombinant FSH Injections Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Middle East & Africa Recombinant FSH Injections Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Recombinant FSH Injections Sales Forecast by Type (2025-2030) & (K Units)
Table 75. Global Recombinant FSH Injections Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Recombinant FSH Injections Sales Forecast by Application (2025-2030) & (K Units)
Table 77. Global Recombinant FSH Injections Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. Gonal-F (Merck) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 79. Gonal-F (Merck) Recombinant FSH Injections Product Portfolios and Specifications
Table 80. Gonal-F (Merck) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Gonal-F (Merck) Main Business
Table 82. Gonal-F (Merck) Latest Developments
Table 83. Follistim (Organon) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 84. Follistim (Organon) Recombinant FSH Injections Product Portfolios and Specifications
Table 85. Follistim (Organon) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Follistim (Organon) Main Business
Table 87. Follistim (Organon) Latest Developments
Table 88. Bravelle (Ferring) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 89. Bravelle (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
Table 90. Bravelle (Ferring) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Bravelle (Ferring) Main Business
Table 92. Bravelle (Ferring) Latest Developments
Table 93. Menopur (Ferring) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 94. Menopur (Ferring) Recombinant FSH Injections Product Portfolios and Specifications
Table 95. Menopur (Ferring) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Menopur (Ferring) Main Business
Table 97. Menopur (Ferring) Latest Developments
Table 98. Fostimon (IBSA) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 99. Fostimon (IBSA) Recombinant FSH Injections Product Portfolios and Specifications
Table 100. Fostimon (IBSA) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Fostimon (IBSA) Main Business
Table 102. Fostimon (IBSA) Latest Developments
Table 103. Puregon (Organon) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 104. Puregon (Organon) Recombinant FSH Injections Product Portfolios and Specifications
Table 105. Puregon (Organon) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Puregon (Organon) Main Business
Table 107. Puregon (Organon) Latest Developments
Table 108. BEMFOLA (Gedeon Richter) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 109. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Product Portfolios and Specifications
Table 110. BEMFOLA (Gedeon Richter) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. BEMFOLA (Gedeon Richter) Main Business
Table 112. BEMFOLA (Gedeon Richter) Latest Developments
Table 113. Follitrope (LG Chem) Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 114. Follitrope (LG Chem) Recombinant FSH Injections Product Portfolios and Specifications
Table 115. Follitrope (LG Chem) Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Follitrope (LG Chem) Main Business
Table 117. Follitrope (LG Chem) Latest Developments
Table 118. GenSci Basic Information, Recombinant FSH Injections Manufacturing Base, Sales Area and Its Competitors
Table 119. GenSci Recombinant FSH Injections Product Portfolios and Specifications
Table 120. GenSci Recombinant FSH Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. GenSci Main Business
Table 122. GenSci Latest Developments
LIST OF FIGURES
Figure 1. Picture of Recombinant FSH Injections
Figure 2. Recombinant FSH Injections Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant FSH Injections Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Recombinant FSH Injections Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Recombinant FSH Injections Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Powder
Figure 10. Product Picture of Liquid
Figure 11. Global Recombinant FSH Injections Sales Market Share by Type in 2023
Figure 12. Global Recombinant FSH Injections Revenue Market Share by Type (2019-2024)
Figure 13. Recombinant FSH Injections Consumed in IVF and Embryo Transfer
Figure 14. Global Recombinant FSH Injections Market: IVF and Embryo Transfer (2019-2024) & (K Units)
Figure 15. Recombinant FSH Injections Consumed in Infertility Treatment
Figure 16. Global Recombinant FSH Injections Market: Infertility Treatment (2019-2024) & (K Units)
Figure 17. Global Recombinant FSH Injections Sales Market Share by Application (2023)
Figure 18. Global Recombinant FSH Injections Revenue Market Share by Application in 2023
Figure 19. Recombinant FSH Injections Sales Market by Company in 2023 (K Units)
Figure 20. Global Recombinant FSH Injections Sales Market Share by Company in 2023
Figure 21. Recombinant FSH Injections Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Recombinant FSH Injections Revenue Market Share by Company in 2023
Figure 23. Global Recombinant FSH Injections Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Recombinant FSH Injections Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Recombinant FSH Injections Sales 2019-2024 (K Units)
Figure 26. Americas Recombinant FSH Injections Revenue 2019-2024 ($ Millions)
Figure 27. APAC Recombinant FSH Injections Sales 2019-2024 (K Units)
Figure 28. APAC Recombinant FSH Injections Revenue 2019-2024 ($ Millions)
Figure 29. Europe Recombinant FSH Injections Sales 2019-2024 (K Units)
Figure 30. Europe Recombinant FSH Injections Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Recombinant FSH Injections Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Recombinant FSH Injections Revenue 2019-2024 ($ Millions)
Figure 33. Americas Recombinant FSH Injections Sales Market Share by Country in 2023
Figure 34. Americas Recombinant FSH Injections Revenue Market Share by Country in 2023
Figure 35. Americas Recombinant FSH Injections Sales Market Share by Type (2019-2024)
Figure 36. Americas Recombinant FSH Injections Sales Market Share by Application (2019-2024)
Figure 37. United States Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Recombinant FSH Injections Sales Market Share by Region in 2023
Figure 42. APAC Recombinant FSH Injections Revenue Market Share by Regions in 2023
Figure 43. APAC Recombinant FSH Injections Sales Market Share by Type (2019-2024)
Figure 44. APAC Recombinant FSH Injections Sales Market Share by Application (2019-2024)
Figure 45. China Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Recombinant FSH Injections Sales Market Share by Country in 2023
Figure 53. Europe Recombinant FSH Injections Revenue Market Share by Country in 2023
Figure 54. Europe Recombinant FSH Injections Sales Market Share by Type (2019-2024)
Figure 55. Europe Recombinant FSH Injections Sales Market Share by Application (2019-2024)
Figure 56. Germany Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Recombinant FSH Injections Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Recombinant FSH Injections Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Recombinant FSH Injections Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Recombinant FSH Injections Sales Market Share by Application (2019-2024)
Figure 65. Egypt Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Recombinant FSH Injections in 2023
Figure 71. Manufacturing Process Analysis of Recombinant FSH Injections
Figure 72. Industry Chain Structure of Recombinant FSH Injections
Figure 73. Channels of Distribution
Figure 74. Global Recombinant FSH Injections Sales Market Forecast by Region (2025-2030)
Figure 75. Global Recombinant FSH Injections Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Recombinant FSH Injections Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Recombinant FSH Injections Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Recombinant FSH Injections Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Recombinant FSH Injections Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Recombinant FSH Injections
Figure 2. Recombinant FSH Injections Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant FSH Injections Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Recombinant FSH Injections Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Recombinant FSH Injections Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Powder
Figure 10. Product Picture of Liquid
Figure 11. Global Recombinant FSH Injections Sales Market Share by Type in 2023
Figure 12. Global Recombinant FSH Injections Revenue Market Share by Type (2019-2024)
Figure 13. Recombinant FSH Injections Consumed in IVF and Embryo Transfer
Figure 14. Global Recombinant FSH Injections Market: IVF and Embryo Transfer (2019-2024) & (K Units)
Figure 15. Recombinant FSH Injections Consumed in Infertility Treatment
Figure 16. Global Recombinant FSH Injections Market: Infertility Treatment (2019-2024) & (K Units)
Figure 17. Global Recombinant FSH Injections Sales Market Share by Application (2023)
Figure 18. Global Recombinant FSH Injections Revenue Market Share by Application in 2023
Figure 19. Recombinant FSH Injections Sales Market by Company in 2023 (K Units)
Figure 20. Global Recombinant FSH Injections Sales Market Share by Company in 2023
Figure 21. Recombinant FSH Injections Revenue Market by Company in 2023 ($ Million)
Figure 22. Global Recombinant FSH Injections Revenue Market Share by Company in 2023
Figure 23. Global Recombinant FSH Injections Sales Market Share by Geographic Region (2019-2024)
Figure 24. Global Recombinant FSH Injections Revenue Market Share by Geographic Region in 2023
Figure 25. Americas Recombinant FSH Injections Sales 2019-2024 (K Units)
Figure 26. Americas Recombinant FSH Injections Revenue 2019-2024 ($ Millions)
Figure 27. APAC Recombinant FSH Injections Sales 2019-2024 (K Units)
Figure 28. APAC Recombinant FSH Injections Revenue 2019-2024 ($ Millions)
Figure 29. Europe Recombinant FSH Injections Sales 2019-2024 (K Units)
Figure 30. Europe Recombinant FSH Injections Revenue 2019-2024 ($ Millions)
Figure 31. Middle East & Africa Recombinant FSH Injections Sales 2019-2024 (K Units)
Figure 32. Middle East & Africa Recombinant FSH Injections Revenue 2019-2024 ($ Millions)
Figure 33. Americas Recombinant FSH Injections Sales Market Share by Country in 2023
Figure 34. Americas Recombinant FSH Injections Revenue Market Share by Country in 2023
Figure 35. Americas Recombinant FSH Injections Sales Market Share by Type (2019-2024)
Figure 36. Americas Recombinant FSH Injections Sales Market Share by Application (2019-2024)
Figure 37. United States Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 38. Canada Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 39. Mexico Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 40. Brazil Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 41. APAC Recombinant FSH Injections Sales Market Share by Region in 2023
Figure 42. APAC Recombinant FSH Injections Revenue Market Share by Regions in 2023
Figure 43. APAC Recombinant FSH Injections Sales Market Share by Type (2019-2024)
Figure 44. APAC Recombinant FSH Injections Sales Market Share by Application (2019-2024)
Figure 45. China Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 46. Japan Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 47. South Korea Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 48. Southeast Asia Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 49. India Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 50. Australia Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 51. China Taiwan Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 52. Europe Recombinant FSH Injections Sales Market Share by Country in 2023
Figure 53. Europe Recombinant FSH Injections Revenue Market Share by Country in 2023
Figure 54. Europe Recombinant FSH Injections Sales Market Share by Type (2019-2024)
Figure 55. Europe Recombinant FSH Injections Sales Market Share by Application (2019-2024)
Figure 56. Germany Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 57. France Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 58. UK Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 59. Italy Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 60. Russia Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 61. Middle East & Africa Recombinant FSH Injections Sales Market Share by Country in 2023
Figure 62. Middle East & Africa Recombinant FSH Injections Revenue Market Share by Country in 2023
Figure 63. Middle East & Africa Recombinant FSH Injections Sales Market Share by Type (2019-2024)
Figure 64. Middle East & Africa Recombinant FSH Injections Sales Market Share by Application (2019-2024)
Figure 65. Egypt Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 66. South Africa Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 67. Israel Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 68. Turkey Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 69. GCC Country Recombinant FSH Injections Revenue Growth 2019-2024 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Recombinant FSH Injections in 2023
Figure 71. Manufacturing Process Analysis of Recombinant FSH Injections
Figure 72. Industry Chain Structure of Recombinant FSH Injections
Figure 73. Channels of Distribution
Figure 74. Global Recombinant FSH Injections Sales Market Forecast by Region (2025-2030)
Figure 75. Global Recombinant FSH Injections Revenue Market Share Forecast by Region (2025-2030)
Figure 76. Global Recombinant FSH Injections Sales Market Share Forecast by Type (2025-2030)
Figure 77. Global Recombinant FSH Injections Revenue Market Share Forecast by Type (2025-2030)
Figure 78. Global Recombinant FSH Injections Sales Market Share Forecast by Application (2025-2030)
Figure 79. Global Recombinant FSH Injections Revenue Market Share Forecast by Application (2025-2030)
